Earnings Call · Q4 FY2023·2023-08-03

Q4 23EPS -5.33%·Rev n/aQ3 23EPS +5.66%·Rev n/aQ2 23EPS +2.47%·Rev n/aQ1 23EPS -5.63%·Rev n/a⚠ consensus missing

RESMED INC RMD

Amy Wakeham — Chief Communications and Investor Relations Officer

Mick Farrell — Chief Executive Officer

Brett Sandercock — Chief Financial Officer

−18.5%1d on move date−18.1% vs SPY3d−18.5%5d−19.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RMD calls or request research access.

More RMD calls Browse calls Request research access